Shineco, Inc.
Shineco, Inc. TYHT Peers
See (TYHT) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TYHT | $11.09 | -3.90% | 229.2M | -1.61 | -$6.91 | N/A |
| ZTS | $165.40 | -0.52% | 73.6B | 29.69 | $5.57 | +1.13% |
| HLN | $11.28 | +0.45% | 50.9B | 26.86 | $0.42 | +1.49% |
| TAK | $14.59 | -0.58% | 45.9B | 63.41 | $0.23 | +4.05% |
| TEVA | $18.14 | +2.43% | 20.8B | -15.77 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14B | -180.64 | -$0.73 | N/A |
| NBIX | $123.03 | +0.32% | 12.2B | 41.56 | $2.96 | N/A |
| RDY | $14.57 | -1.25% | 12.1B | 18.21 | $0.80 | +0.66% |
| CTLT | $63.48 | N/A | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $8.59 | -0.12% | 10.1B | -2.70 | -$3.18 | +5.63% |
Stock Comparison
TYHT vs ZTS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ZTS has a market cap of 73.6B. Regarding current trading prices, TYHT is priced at $11.09, while ZTS trades at $165.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ZTS's P/E ratio is 29.69. In terms of profitability, TYHT's ROE is -1.41%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, TYHT is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs HLN Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, HLN has a market cap of 50.9B. Regarding current trading prices, TYHT is priced at $11.09, while HLN trades at $11.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas HLN's P/E ratio is 26.86. In terms of profitability, TYHT's ROE is -1.41%, compared to HLN's ROE of +0.09%. Regarding short-term risk, TYHT is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TAK Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TAK has a market cap of 45.9B. Regarding current trading prices, TYHT is priced at $11.09, while TAK trades at $14.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TAK's P/E ratio is 63.41. In terms of profitability, TYHT's ROE is -1.41%, compared to TAK's ROE of +0.04%. Regarding short-term risk, TYHT is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TEVA Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TEVA has a market cap of 20.8B. Regarding current trading prices, TYHT is priced at $11.09, while TEVA trades at $18.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TEVA's P/E ratio is -15.77. In terms of profitability, TYHT's ROE is -1.41%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, TYHT is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ITCI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, TYHT is priced at $11.09, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ITCI's P/E ratio is -180.64. In terms of profitability, TYHT's ROE is -1.41%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, TYHT is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs NBIX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, NBIX has a market cap of 12.2B. Regarding current trading prices, TYHT is priced at $11.09, while NBIX trades at $123.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas NBIX's P/E ratio is 41.56. In terms of profitability, TYHT's ROE is -1.41%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, TYHT is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs RDY Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, RDY has a market cap of 12.1B. Regarding current trading prices, TYHT is priced at $11.09, while RDY trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas RDY's P/E ratio is 18.21. In terms of profitability, TYHT's ROE is -1.41%, compared to RDY's ROE of +0.18%. Regarding short-term risk, TYHT is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs CTLT Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, TYHT is priced at $11.09, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CTLT's P/E ratio is -27.84. In terms of profitability, TYHT's ROE is -1.41%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, TYHT is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs VTRS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, VTRS has a market cap of 10.1B. Regarding current trading prices, TYHT is priced at $11.09, while VTRS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas VTRS's P/E ratio is -2.70. In terms of profitability, TYHT's ROE is -1.41%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, TYHT is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs RGC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, RGC has a market cap of 6.8B. Regarding current trading prices, TYHT is priced at $11.09, while RGC trades at $520.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas RGC's P/E ratio is -1531.00. In terms of profitability, TYHT's ROE is -1.41%, compared to RGC's ROE of -0.25%. Regarding short-term risk, TYHT is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs ELAN Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ELAN has a market cap of 6.7B. Regarding current trading prices, TYHT is priced at $11.09, while ELAN trades at $13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ELAN's P/E ratio is 17.87. In terms of profitability, TYHT's ROE is -1.41%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, TYHT is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs LNTH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, LNTH has a market cap of 5.1B. Regarding current trading prices, TYHT is priced at $11.09, while LNTH trades at $74.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas LNTH's P/E ratio is 21.13. In terms of profitability, TYHT's ROE is -1.41%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, TYHT is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs PRGO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PRGO has a market cap of 3.7B. Regarding current trading prices, TYHT is priced at $11.09, while PRGO trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PRGO's P/E ratio is -22.58. In terms of profitability, TYHT's ROE is -1.41%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, TYHT is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ALVO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ALVO has a market cap of 3.4B. Regarding current trading prices, TYHT is priced at $11.09, while ALVO trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ALVO's P/E ratio is 30.22. In terms of profitability, TYHT's ROE is -1.41%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, TYHT is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs AMRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AMRX has a market cap of 3.4B. Regarding current trading prices, TYHT is priced at $11.09, while AMRX trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AMRX's P/E ratio is -180.25. In terms of profitability, TYHT's ROE is -1.41%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, TYHT is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ALVOW Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ALVOW has a market cap of 3.3B. Regarding current trading prices, TYHT is priced at $11.09, while ALVOW trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ALVOW's P/E ratio is N/A. In terms of profitability, TYHT's ROE is -1.41%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, TYHT is more volatile compared to ALVOW. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs HCM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, HCM has a market cap of 2.3B. Regarding current trading prices, TYHT is priced at $11.09, while HCM trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas HCM's P/E ratio is 66.15. In terms of profitability, TYHT's ROE is -1.41%, compared to HCM's ROE of +0.05%. Regarding short-term risk, TYHT is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs DCPH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, TYHT is priced at $11.09, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas DCPH's P/E ratio is -11.58. In terms of profitability, TYHT's ROE is -1.41%, compared to DCPH's ROE of -0.52%. Regarding short-term risk, TYHT is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs BGM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BGM has a market cap of 2.1B. Regarding current trading prices, TYHT is priced at $11.09, while BGM trades at $11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BGM's P/E ratio is -58.35. In terms of profitability, TYHT's ROE is -1.41%, compared to BGM's ROE of -0.03%. Regarding short-term risk, TYHT is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs EMBCV Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, TYHT is priced at $11.09, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EMBCV's P/E ratio is N/A. In terms of profitability, TYHT's ROE is -1.41%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, TYHT is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs SUPN Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SUPN has a market cap of 1.8B. Regarding current trading prices, TYHT is priced at $11.09, while SUPN trades at $32.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SUPN's P/E ratio is 28.96. In terms of profitability, TYHT's ROE is -1.41%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, TYHT is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs BHC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BHC has a market cap of 1.7B. Regarding current trading prices, TYHT is priced at $11.09, while BHC trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BHC's P/E ratio is -37.92. In terms of profitability, TYHT's ROE is -1.41%, compared to BHC's ROE of +0.05%. Regarding short-term risk, TYHT is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TARO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, TYHT is priced at $11.09, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TARO's P/E ratio is 30.05. In terms of profitability, TYHT's ROE is -1.41%, compared to TARO's ROE of +0.03%. Regarding short-term risk, TYHT is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs INDV Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, INDV has a market cap of 1.5B. Regarding current trading prices, TYHT is priced at $11.09, while INDV trades at $12.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas INDV's P/E ratio is -240.60. In terms of profitability, TYHT's ROE is -1.41%, compared to INDV's ROE of -0.01%. Regarding short-term risk, TYHT is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs EVO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EVO has a market cap of 1.4B. Regarding current trading prices, TYHT is priced at $11.09, while EVO trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EVO's P/E ratio is -5.91. In terms of profitability, TYHT's ROE is -1.41%, compared to EVO's ROE of -0.22%. Regarding short-term risk, TYHT is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ANIP Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ANIP has a market cap of 1.3B. Regarding current trading prices, TYHT is priced at $11.09, while ANIP trades at $57.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ANIP's P/E ratio is -48.99. In terms of profitability, TYHT's ROE is -1.41%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, TYHT is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs AMPH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AMPH has a market cap of 1.2B. Regarding current trading prices, TYHT is priced at $11.09, while AMPH trades at $25.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AMPH's P/E ratio is 9.16. In terms of profitability, TYHT's ROE is -1.41%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, TYHT is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs PCRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PCRX has a market cap of 1.2B. Regarding current trading prices, TYHT is priced at $11.09, while PCRX trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PCRX's P/E ratio is -11.41. In terms of profitability, TYHT's ROE is -1.41%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, TYHT is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs DVAX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, DVAX has a market cap of 1.1B. Regarding current trading prices, TYHT is priced at $11.09, while DVAX trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas DVAX's P/E ratio is -19.00. In terms of profitability, TYHT's ROE is -1.41%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, TYHT is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs PAHC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PAHC has a market cap of 993.9M. Regarding current trading prices, TYHT is priced at $11.09, while PAHC trades at $24.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PAHC's P/E ratio is 31.44. In terms of profitability, TYHT's ROE is -1.41%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, TYHT is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs HROW Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, HROW has a market cap of 951.3M. Regarding current trading prices, TYHT is priced at $11.09, while HROW trades at $25.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas HROW's P/E ratio is -42.49. In terms of profitability, TYHT's ROE is -1.41%, compared to HROW's ROE of -0.36%. Regarding short-term risk, TYHT is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs COLL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, COLL has a market cap of 929.2M. Regarding current trading prices, TYHT is priced at $11.09, while COLL trades at $28.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas COLL's P/E ratio is 23.70. In terms of profitability, TYHT's ROE is -1.41%, compared to COLL's ROE of +0.19%. Regarding short-term risk, TYHT is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs PETQ Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, TYHT is priced at $11.09, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PETQ's P/E ratio is 83.73. In terms of profitability, TYHT's ROE is -1.41%, compared to PETQ's ROE of +0.06%. Regarding short-term risk, TYHT is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs AVDL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AVDL has a market cap of 875.5M. Regarding current trading prices, TYHT is priced at $11.09, while AVDL trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AVDL's P/E ratio is -34.81. In terms of profitability, TYHT's ROE is -1.41%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, TYHT is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs CRON Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CRON has a market cap of 776.6M. Regarding current trading prices, TYHT is priced at $11.09, while CRON trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CRON's P/E ratio is 14.39. In terms of profitability, TYHT's ROE is -1.41%, compared to CRON's ROE of +0.05%. Regarding short-term risk, TYHT is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs EMBC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EMBC has a market cap of 616.6M. Regarding current trading prices, TYHT is priced at $11.09, while EMBC trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EMBC's P/E ratio is 11.85. In terms of profitability, TYHT's ROE is -1.41%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, TYHT is less volatile compared to EMBC. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs EOLS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EOLS has a market cap of 599.6M. Regarding current trading prices, TYHT is priced at $11.09, while EOLS trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EOLS's P/E ratio is -10.45. In terms of profitability, TYHT's ROE is -1.41%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, TYHT is less volatile compared to EOLS. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs BDSI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, TYHT is priced at $11.09, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BDSI's P/E ratio is 6.82. In terms of profitability, TYHT's ROE is -1.41%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, TYHT is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TLRY Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TLRY has a market cap of 461M. Regarding current trading prices, TYHT is priced at $11.09, while TLRY trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TLRY's P/E ratio is -0.41. In terms of profitability, TYHT's ROE is -1.41%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, TYHT is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs SIGA Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SIGA has a market cap of 435.1M. Regarding current trading prices, TYHT is priced at $11.09, while SIGA trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SIGA's P/E ratio is 9.09. In terms of profitability, TYHT's ROE is -1.41%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, TYHT is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ZYBT Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ZYBT has a market cap of 417M. Regarding current trading prices, TYHT is priced at $11.09, while ZYBT trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ZYBT's P/E ratio is 146.67. In terms of profitability, TYHT's ROE is -1.41%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, TYHT is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs KMDA Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, KMDA has a market cap of 396.2M. Regarding current trading prices, TYHT is priced at $11.09, while KMDA trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas KMDA's P/E ratio is 24.61. In terms of profitability, TYHT's ROE is -1.41%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, TYHT is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ORGO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ORGO has a market cap of 364.1M. Regarding current trading prices, TYHT is priced at $11.09, while ORGO trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ORGO's P/E ratio is -17.94. In terms of profitability, TYHT's ROE is -1.41%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, TYHT is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs EBS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EBS has a market cap of 353.1M. Regarding current trading prices, TYHT is priced at $11.09, while EBS trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EBS's P/E ratio is -2.52. In terms of profitability, TYHT's ROE is -1.41%, compared to EBS's ROE of -0.27%. Regarding short-term risk, TYHT is less volatile compared to EBS. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs SNDL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SNDL has a market cap of 334.5M. Regarding current trading prices, TYHT is priced at $11.09, while SNDL trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SNDL's P/E ratio is -4.33. In terms of profitability, TYHT's ROE is -1.41%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, TYHT is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs CGC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CGC has a market cap of 316.9M. Regarding current trading prices, TYHT is priced at $11.09, while CGC trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CGC's P/E ratio is -0.48. In terms of profitability, TYHT's ROE is -1.41%, compared to CGC's ROE of -0.88%. Regarding short-term risk, TYHT is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs TKNO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TKNO has a market cap of 310M. Regarding current trading prices, TYHT is priced at $11.09, while TKNO trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TKNO's P/E ratio is -12.61. In terms of profitability, TYHT's ROE is -1.41%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, TYHT is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ACB Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ACB has a market cap of 303M. Regarding current trading prices, TYHT is priced at $11.09, while ACB trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ACB's P/E ratio is 29.05. In terms of profitability, TYHT's ROE is -1.41%, compared to ACB's ROE of -0.06%. Regarding short-term risk, TYHT is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ALIM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, TYHT is priced at $11.09, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ALIM's P/E ratio is 5.28. In terms of profitability, TYHT's ROE is -1.41%, compared to ALIM's ROE of -0.34%. Regarding short-term risk, TYHT is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs AQST Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AQST has a market cap of 271.2M. Regarding current trading prices, TYHT is priced at $11.09, while AQST trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AQST's P/E ratio is -4.71. In terms of profitability, TYHT's ROE is -1.41%, compared to AQST's ROE of +1.07%. Regarding short-term risk, TYHT is less volatile compared to AQST. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs LNDC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, TYHT is priced at $11.09, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas LNDC's P/E ratio is -4.04. In terms of profitability, TYHT's ROE is -1.41%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, TYHT is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs LFCR Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, LFCR has a market cap of 255.1M. Regarding current trading prices, TYHT is priced at $11.09, while LFCR trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas LFCR's P/E ratio is -4.69. In terms of profitability, TYHT's ROE is -1.41%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, TYHT is less volatile compared to LFCR. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs DERM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, DERM has a market cap of 184.3M. Regarding current trading prices, TYHT is priced at $11.09, while DERM trades at $7.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas DERM's P/E ratio is -21.38. In terms of profitability, TYHT's ROE is -1.41%, compared to DERM's ROE of -0.52%. Regarding short-term risk, TYHT is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs OGI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, OGI has a market cap of 180.7M. Regarding current trading prices, TYHT is priced at $11.09, while OGI trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas OGI's P/E ratio is 11.25. In terms of profitability, TYHT's ROE is -1.41%, compared to OGI's ROE of +0.05%. Regarding short-term risk, TYHT is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs REPH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, TYHT is priced at $11.09, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas REPH's P/E ratio is -8.04. In terms of profitability, TYHT's ROE is -1.41%, compared to REPH's ROE of -0.15%. Regarding short-term risk, TYHT is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs ESPR Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ESPR has a market cap of 165.4M. Regarding current trading prices, TYHT is priced at $11.09, while ESPR trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ESPR's P/E ratio is -0.98. In terms of profitability, TYHT's ROE is -1.41%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, TYHT is less volatile compared to ESPR. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs BIOA Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BIOA has a market cap of 142.7M. Regarding current trading prices, TYHT is priced at $11.09, while BIOA trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BIOA's P/E ratio is -2.01. In terms of profitability, TYHT's ROE is -1.41%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, TYHT is less volatile compared to BIOA. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs THTX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, THTX has a market cap of 119.1M. Regarding current trading prices, TYHT is priced at $11.09, while THTX trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas THTX's P/E ratio is -37.00. In terms of profitability, TYHT's ROE is -1.41%, compared to THTX's ROE of +0.16%. Regarding short-term risk, TYHT is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs SCTL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, TYHT is priced at $11.09, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SCTL's P/E ratio is -7.86. In terms of profitability, TYHT's ROE is -1.41%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, TYHT is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs PROC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, TYHT is priced at $11.09, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PROC's P/E ratio is 1.53. In terms of profitability, TYHT's ROE is -1.41%, compared to PROC's ROE of -2.22%. Regarding short-term risk, TYHT is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs CRDL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CRDL has a market cap of 105.8M. Regarding current trading prices, TYHT is priced at $11.09, while CRDL trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CRDL's P/E ratio is -3.76. In terms of profitability, TYHT's ROE is -1.41%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, TYHT is less volatile compared to CRDL. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs OPTN Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, TYHT is priced at $11.09, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas OPTN's P/E ratio is -4.42. In terms of profitability, TYHT's ROE is -1.41%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, TYHT is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs IRWD Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, IRWD has a market cap of 95.9M. Regarding current trading prices, TYHT is priced at $11.09, while IRWD trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas IRWD's P/E ratio is -3.12. In terms of profitability, TYHT's ROE is -1.41%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, TYHT is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs ZOM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, TYHT is priced at $11.09, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ZOM's P/E ratio is -1.62. In terms of profitability, TYHT's ROE is -1.41%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, TYHT is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs GRVI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, TYHT is priced at $11.09, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas GRVI's P/E ratio is 26.05. In terms of profitability, TYHT's ROE is -1.41%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, TYHT is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs CPIX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CPIX has a market cap of 87.4M. Regarding current trading prices, TYHT is priced at $11.09, while CPIX trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CPIX's P/E ratio is -24.33. In terms of profitability, TYHT's ROE is -1.41%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, TYHT is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs INCR Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, INCR has a market cap of 72.2M. Regarding current trading prices, TYHT is priced at $11.09, while INCR trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas INCR's P/E ratio is -3.65. In terms of profitability, TYHT's ROE is -1.41%, compared to INCR's ROE of -0.07%. Regarding short-term risk, TYHT is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ZYNE Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, TYHT is priced at $11.09, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, TYHT's ROE is -1.41%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, TYHT is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs SSIC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, TYHT is priced at $11.09, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SSIC's P/E ratio is 11.93. In terms of profitability, TYHT's ROE is -1.41%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, TYHT is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs ASRT Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ASRT has a market cap of 66.3M. Regarding current trading prices, TYHT is priced at $11.09, while ASRT trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ASRT's P/E ratio is -2.16. In terms of profitability, TYHT's ROE is -1.41%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, TYHT is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs VLNS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, TYHT is priced at $11.09, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas VLNS's P/E ratio is -1.03. In terms of profitability, TYHT's ROE is -1.41%, compared to VLNS's ROE of N/A. Regarding short-term risk, TYHT is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs JUPW Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, TYHT is priced at $11.09, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas JUPW's P/E ratio is -2.41. In terms of profitability, TYHT's ROE is -1.41%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, TYHT is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs SXTC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SXTC has a market cap of 39.6M. Regarding current trading prices, TYHT is priced at $11.09, while SXTC trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SXTC's P/E ratio is 0.01. In terms of profitability, TYHT's ROE is -1.41%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, TYHT is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs QLI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, TYHT is priced at $11.09, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas QLI's P/E ratio is -4.92. In terms of profitability, TYHT's ROE is -1.41%, compared to QLI's ROE of -0.16%. Regarding short-term risk, TYHT is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs SCYX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SCYX has a market cap of 36.5M. Regarding current trading prices, TYHT is priced at $11.09, while SCYX trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SCYX's P/E ratio is -1.67. In terms of profitability, TYHT's ROE is -1.41%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, TYHT is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs QNTM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, QNTM has a market cap of 34.1M. Regarding current trading prices, TYHT is priced at $11.09, while QNTM trades at $11.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas QNTM's P/E ratio is -0.89. In terms of profitability, TYHT's ROE is -1.41%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, TYHT is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs RMTI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, RMTI has a market cap of 32.5M. Regarding current trading prices, TYHT is priced at $11.09, while RMTI trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas RMTI's P/E ratio is -95.00. In terms of profitability, TYHT's ROE is -1.41%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, TYHT is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs HEXO Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, TYHT is priced at $11.09, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas HEXO's P/E ratio is -0.26. In terms of profitability, TYHT's ROE is -1.41%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, TYHT is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs KALA Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, KALA has a market cap of 24.9M. Regarding current trading prices, TYHT is priced at $11.09, while KALA trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas KALA's P/E ratio is -0.52. In terms of profitability, TYHT's ROE is -1.41%, compared to KALA's ROE of -3.69%. Regarding short-term risk, TYHT is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs CYTH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, TYHT is priced at $11.09, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas CYTH's P/E ratio is -0.80. In terms of profitability, TYHT's ROE is -1.41%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, TYHT is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs EGRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, EGRX has a market cap of 21.4M. Regarding current trading prices, TYHT is priced at $11.09, while EGRX trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas EGRX's P/E ratio is 1.99. In terms of profitability, TYHT's ROE is -1.41%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, TYHT is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs GELS Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, GELS has a market cap of 16.8M. Regarding current trading prices, TYHT is priced at $11.09, while GELS trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas GELS's P/E ratio is -7.44. In terms of profitability, TYHT's ROE is -1.41%, compared to GELS's ROE of -0.21%. Regarding short-term risk, TYHT is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TXMD Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TXMD has a market cap of 16.8M. Regarding current trading prices, TYHT is priced at $11.09, while TXMD trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TXMD's P/E ratio is -7.63. In terms of profitability, TYHT's ROE is -1.41%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, TYHT is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs IXHL Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, IXHL has a market cap of 16.7M. Regarding current trading prices, TYHT is priced at $11.09, while IXHL trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas IXHL's P/E ratio is -0.19. In terms of profitability, TYHT's ROE is -1.41%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, TYHT is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs DRRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, DRRX has a market cap of 16.1M. Regarding current trading prices, TYHT is priced at $11.09, while DRRX trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas DRRX's P/E ratio is -1.08. In terms of profitability, TYHT's ROE is -1.41%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, TYHT is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs FLGC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, FLGC has a market cap of 15.5M. Regarding current trading prices, TYHT is priced at $11.09, while FLGC trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas FLGC's P/E ratio is -0.72. In terms of profitability, TYHT's ROE is -1.41%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, TYHT is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs SISI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, SISI has a market cap of 15.4M. Regarding current trading prices, TYHT is priced at $11.09, while SISI trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas SISI's P/E ratio is N/A. In terms of profitability, TYHT's ROE is -1.41%, compared to SISI's ROE of -1.41%. Regarding short-term risk, TYHT is less volatile compared to SISI. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs ACRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, TYHT is priced at $11.09, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas ACRX's P/E ratio is -0.31. In terms of profitability, TYHT's ROE is -1.41%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, TYHT is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs PRPH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, PRPH has a market cap of 14.5M. Regarding current trading prices, TYHT is priced at $11.09, while PRPH trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas PRPH's P/E ratio is -0.16. In terms of profitability, TYHT's ROE is -1.41%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, TYHT is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs COSM Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, COSM has a market cap of 13.5M. Regarding current trading prices, TYHT is priced at $11.09, while COSM trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas COSM's P/E ratio is -0.43. In terms of profitability, TYHT's ROE is -1.41%, compared to COSM's ROE of -0.51%. Regarding short-term risk, TYHT is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs AYTU Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AYTU has a market cap of 11.8M. Regarding current trading prices, TYHT is priced at $11.09, while AYTU trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AYTU's P/E ratio is -1.28. In terms of profitability, TYHT's ROE is -1.41%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, TYHT is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs AGRX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, TYHT is priced at $11.09, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas AGRX's P/E ratio is -0.89. In terms of profitability, TYHT's ROE is -1.41%, compared to AGRX's ROE of +1.04%. Regarding short-term risk, TYHT is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs TLPH Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, TLPH has a market cap of 10.1M. Regarding current trading prices, TYHT is priced at $11.09, while TLPH trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas TLPH's P/E ratio is -1.12. In terms of profitability, TYHT's ROE is -1.41%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, TYHT is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs YCBD Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, YCBD has a market cap of 8.6M. Regarding current trading prices, TYHT is priced at $11.09, while YCBD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas YCBD's P/E ratio is 0.01. In terms of profitability, TYHT's ROE is -1.41%, compared to YCBD's ROE of -8.81%. Regarding short-term risk, TYHT is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs IMCC Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, IMCC has a market cap of 8.4M. Regarding current trading prices, TYHT is priced at $11.09, while IMCC trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas IMCC's P/E ratio is -1.98. In terms of profitability, TYHT's ROE is -1.41%, compared to IMCC's ROE of -1.52%. Regarding short-term risk, TYHT is less volatile compared to IMCC. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs BFRIW Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BFRIW has a market cap of 8.3M. Regarding current trading prices, TYHT is priced at $11.09, while BFRIW trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BFRIW's P/E ratio is -0.10. In terms of profitability, TYHT's ROE is -1.41%, compared to BFRIW's ROE of -2.16%. Regarding short-term risk, TYHT is less volatile compared to BFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs NLTX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, TYHT is priced at $11.09, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas NLTX's P/E ratio is -0.28. In terms of profitability, TYHT's ROE is -1.41%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, TYHT is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.
TYHT vs LCI Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, TYHT is priced at $11.09, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas LCI's P/E ratio is -0.04. In terms of profitability, TYHT's ROE is -1.41%, compared to LCI's ROE of +1.66%. Regarding short-term risk, TYHT is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for TYHT.
TYHT vs BGXX Comparison
TYHT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TYHT stands at 229.2M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, TYHT is priced at $11.09, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TYHT currently has a P/E ratio of -1.61, whereas BGXX's P/E ratio is -0.76. In terms of profitability, TYHT's ROE is -1.41%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, TYHT is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for TYHT.